Dockets
Federal rulemakings, soonest-closing first — each gathers its documents and comments.
DEA ▾
Quagen Pharmaceuticals, LLC (DEA 1701)
ANI Pharmaceuticals Inc. (DEA 1708)
Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA1632)
VHG Labs DBA LGC Standards (DEA 1729)
Schedules of Controlled Substances: Placement of ODesmethyltramadol in Schedule I (DEA1641)
Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act (DEA1665)
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
**DO NOT USE** Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I (DEA1644)
Schedules of Controlled Substance: Temporary Placement of 7-Hydroxy mitragynine Above a Specified Threshold in Schedule I (DEA1570)
Recently Posted DEA Rules and Notices